Omeros (OMER) FCF Margin Growth (3y) (2013 - 2022)

Omeros (OMER) FCF Margin Growth (3y) (2013 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin Growth (3y) (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 15,064.00
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 723.00
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -1,409.00
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Omeros 707.67 Mn 707.67 Mn 9.31 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2022 -13,035.00
Mar 31, 2022 -15,688.00
Dec 31, 2021 13,531.00
Sep 30, 2021 72,292.00
Jun 30, 2021 178,391.00
Mar 31, 2021 53,167.00
Dec 31, 2020 -14,281.00
Sep 30, 2020 -8,224.00
Jun 30, 2020 -22,995.00
Mar 31, 2020 6,510.00
Dec 31, 2019 1,563.00
Sep 30, 2019 7,444.00
Jun 30, 2019 6,587.00
Mar 31, 2019 16,384.00
Dec 31, 2018 13,707.00
Sep 30, 2018 -35,226.00
Jun 30, 2018 -135,722.00
Mar 31, 2018 378,126.00
Dec 31, 2017 869,579.00
Sep 30, 2017 740,236.00